Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Joins® for Lumbar Facetogenic Pain
NCT06204952Not yet recruiting
- Start
- Jun 2024
- Primary completion
- Jan 2026
- Modality
- Botanical Extract
01
Overview
Randomised, double-blind trial of JOINS in lumbar facet joint syndrome (LFS) (2 arms). Primary endpoint: Numeric Rating Scale at 12 weeks. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
JOINS
03
Conditions
lumbar facet joint syndrome (LFS)
Beyond the preview
Go deeper on NCT06204952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06204952.